A study on the safety and immune response to an unadjuvanted RSV Maternal vaccine, in high risk pregnant women aged 15 to 49 years and infants born to the vaccinated mothers

Trial Identifier: 214725
Sponsor: GlaxoSmithKline
Start Date: August 2021
Primary Completion Date: May 2023
Study Completion Date: May 2023
Condition: Respiratory Syncytial Virus Immunisation

Trial Locations

Country Location
Brazil Caxias do Sul, Brazil, 95070-560
Brazil RibeirAo PretoSP, Brazil, 14048-900
Brazil Santa Maria, Brazil, 97105-900
Canada, NS Halifax, NS, Canada, B3K 6R8
Canada, QC Montreal, QC, Canada, H3T 1C5
Finland Helsinki, Finland, 00290
India Bhubaneswar, India, 751019
India Mysuru, India, 570015
Italy Messina, Italy, 98124
Italy Perugia, Italy, 06129
Italy Prato, Italy, 59100
Panama Panama, Panama, 0801
South Africa Soweto Gauteng, South Africa, 2013
Spain Boadilla del Monte Madrid, Spain, 28660
Spain Madrid, Spain, 28222
Spain Madrid, Spain, 28046
Spain Madrid, Spain, 28041
Spain Malaga, Spain, 29004
Spain TorrejOn Ardoz Madrid, Spain, 28850
United States, AL Birmingham, AL, United States, 35205
United States, AL Dothan, AL, United States, 36305
United States, AL Mobile, AL, United States, 36608
United States, AZ Phoenix, AZ, United States, 85015
United States, LA Covington, LA, United States, 70433
United States, LA Lafayette, LA, United States, 70508
United States, LA Slidell, LA, United States, 70458
United States, MT Missoula, MT, United States, 59804
United States, TX Arlington, TX, United States, 76012
United States, TX Austin, TX, United States, 78705
United States, TX Fort Worth, TX, United States, 76104
United States, TX Grapevine, TX, United States, 76051
United States, TX Houston, TX, United States, 77008
United States, TX League City, TX, United States, 77573
United States, TX Plano, TX, United States, 75093
United States, TX Weatherford, TX, United States, 76086